NONALCOHOLIC FATTY LIVER DISEASE IN RENAL TRANSPLANT RECIPIENTS PROVEN BY TRANSIENT

被引:0
|
作者
Mikolasevic, Ivana [1 ]
Racki, Sanjin [2 ]
Lukenda, Vesna [3 ]
Persic, Martina Pavletic [2 ]
Colic, Marina [2 ]
Devcic, Bosiljka [2 ]
Orlic, Lidija [2 ]
机构
[1] Univ Hosp Rijeka, Rijeka, Croatia
[2] Univ Hosp Ctr Rijeka, Div Internal Med, Dept Nephrol & Dialysis, Rijeka, Croatia
[3] Dr Josip Bencevic Gen Hosp, Dept Internal Med, Slavonski Brod, Croatia
关键词
D O I
暂无
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
SP759
引用
收藏
页码:324 / 325
页数:2
相关论文
共 50 条
  • [1] Nonalcoholic Fatty Liver Disease in Renal Transplant Recipients Proven by Transient Elastography
    Mikolasevic, I.
    Racki, S.
    Lukenda, V.
    Milic, S.
    Pavletic-Persic, M.
    Orlic, L.
    [J]. TRANSPLANTATION PROCEEDINGS, 2014, 46 (05) : 1347 - 1352
  • [2] Nonalcoholic Fatty Liver Disease (NAFLD) And Cardiovascular Risk In Renal Transplant Recipients
    Mikolasevic, Ivana
    Racki, Sanjin
    Zaputovic, Luka
    Lukenda, Vesna
    Sladoje-Martinovic, Branka
    Odic, Lidija
    [J]. KIDNEY & BLOOD PRESSURE RESEARCH, 2014, 39 (04): : 308 - 314
  • [3] Chronic Kidney Disease and Nonalcoholic Fatty Liver Disease Proven by Transient Elastography
    Mikolasevic, Ivana
    Racki, Sanjin
    Bubic, Ivan
    Jelic, Ita
    Stimac, Davor
    Orlic, Lidija
    [J]. KIDNEY & BLOOD PRESSURE RESEARCH, 2013, 37 (4-5): : 305 - 310
  • [4] Nonalcoholic fatty liver disease (NAFLD) proven by transient elastography in patients with coronary heart disease
    Mikolasevic, Ivana
    Orlic, Lidija
    Milic, Sandra
    Lukenda, Vesna
    Racki, Sanjin
    Stimac, Davor
    Avdovic, Ervin
    Zaputovic, Luka
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2014, 126 (15-16) : 474 - 479
  • [5] UTILITY OF METABOLOMIC BIOMARKERS TO IDENTIFY NONALCOHOLIC FATTY LIVER DISEASE IN LIVER TRANSPLANT RECIPIENTS
    Mowry, Christopher J.
    Rinella, Mary E.
    Iruarrizaga-Lejarreta, Marta
    Alonso, Cristina
    Ortiz, Pablo
    Levitsky, Josh
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S1410 - S1410
  • [6] Saroglitazar improves nonalcoholic fatty liver disease and metabolic health in liver transplant recipients
    Siddiqui, Mohammad Shadab
    Parmar, Deven
    Shaikh, Farheen
    Forsgren, Mikael
    Patel, Samarth
    Bui, Anh Tuan
    Boyett, Sherry
    Patel, Vaishali
    Sanyal, Arun J.
    [J]. LIVER TRANSPLANTATION, 2023, 29 (09) : 979 - 986
  • [7] Utility of Metabolomic Biomarkers to Identify Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients
    Mowry, Christopher J.
    Alonso, Cristina
    Iruarrizaga-Lejarreta, Marta
    Ortiz, Pablo
    Levitsky, Josh
    Rinella, Mary
    [J]. TRANSPLANTATION DIRECT, 2021, 7 (12): : E784
  • [8] Histologically Proven Nonalcoholic Fatty Liver Disease and Clinically Related Factors in Recipients after Liver Transplantation
    Kim, Hyeyoung
    Lee, Kyoungbun
    Lee, Kwang-Woong
    Yi, Nam-Joon
    Lee, Hae Won
    Hong, Geun
    Choi, YoungRok
    Suh, Suk-Won
    Jang, Ja June
    Suh, Kyung-Suk
    [J]. LIVER TRANSPLANTATION, 2014, 20 : S135 - S135
  • [9] RADIOMICS BASED CORONARY HEART DISEASE SIGNATURE IN LIVER TRANSPLANT RECIPIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
    Syed, Taseen
    Forsgren, Mikael F.
    Bhati, Chandra
    Patel, Samarth
    Wolver, Susan
    Carper, Moriah C.
    Linge, Jennifer
    Leinhard, Olof Dahlqvist
    Miller, Austin
    Kirkman, Danielle L.
    Siddiqui, Mohammad S.
    [J]. HEPATOLOGY, 2021, 74 : 902A - 902A
  • [10] Cardiovascular and Metabolic Risk Profile of Nonalcoholic Fatty Liver Disease Patients and Liver Transplant Recipients
    An, Kyungeh
    Salyer, Jeanne
    Siddiqui, Shadab
    [J]. CIRCULATION, 2018, 138